Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a...
-
According to BCC Research, AI is helping reduce regulatory uncertainty and accelerate R&D across the genetically modified foods industry.
-
Issued on behalf of GT Biopharma, Inc. Natural killer cells were long overshadowed by T-cell therapies. Now a growing field is trying to unleash them — with the promise of off-the-shelf,...
-
- JAK2 V671F poster presentation showcases potential best-in-class properties, including improved selectivity compared with currently approved JAK inhibitors - - Selective JAK V617F inhibitor,...
-
-- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an updated objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria – ...
-
3 E Network CEO outlines robotics vision: Silicon Innovation, Edge AI, Embodied AI via hardware-software co-design.
-
This season, LEPAS will be right by your side—ready for the next elegant journey to begin.
-
PERTH, Australien, June 12, 2026 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (”Alkane” eller ”bolaget”) är glada att kunna presentera de senaste...
-
Responder rate of 57% at one year in open-label extension (OLE) comparable to 63% at 12 weeks in Phase 2 Avail™ trial Results consistent with restoration of systemic PTH activity through serum...
-
Trondheim, 12 June 2026 NORBIT today announces that segment PIR has received a contract manufacturing order, valued at approximately NOK 225 million from an undisclosed European client in the defence...